Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
36.86
-0.87 (-2.29%)
Aug 7, 2025, 1:11 PM - Market open

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2,1411,8741,2451,5431,7853,001
Upgrade
Market Cap Growth
-21.32%50.56%-19.32%-13.57%-40.52%-8.08%
Upgrade
Enterprise Value
9012744486074882,644
Upgrade
Last Close Price
37.7232.8622.2728.0832.8743.33
Upgrade
PE Ratio
3.342.78--1.11-
Upgrade
PS Ratio
52.9351.3546.40108.35--
Upgrade
PB Ratio
1.601.221.541.401.387.51
Upgrade
P/TBV Ratio
1.601.221.541.401.387.51
Upgrade
EV/Sales Ratio
22.047.5116.7042.61--
Upgrade
Debt / Equity Ratio
0.040.040.090.080.080.26
Upgrade
Asset Turnover
0.040.030.030.01--
Upgrade
Inventory Turnover
11.8613.0821.65---
Upgrade
Quick Ratio
13.4111.0611.4912.5417.176.07
Upgrade
Current Ratio
14.4811.9012.2713.3017.796.75
Upgrade
Return on Equity (ROE)
64.05%57.29%-36.83%-19.38%-42.15%-63.33%
Upgrade
Return on Assets (ROA)
-25.71%-20.47%-22.49%-18.17%-20.65%-24.08%
Upgrade
Return on Capital (ROIC)
-26.91%-21.45%-23.65%-18.88%-24.98%-33.35%
Upgrade
Earnings Yield
29.66%35.95%-28.29%-15.02%89.89%-10.91%
Upgrade
FCF Yield
-18.66%-20.89%-23.87%-20.38%-23.14%-10.16%
Upgrade
Buyback Yield / Dilution
-3.93%-4.02%-1.57%9.36%12.39%-15.01%
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q